Your Heartburn May
Not Be Harmless
Take Charge of your health
A Serious Disease Progression
Understanding heartburn, gastroesophageal reflux disease (GERD), and Barrett's esophagus (BE) is the first step toward getting the right care. Early detection and treatment can reduce your risk of progressing to esophageal adenocarcinoma (EAC).1,2
GET MORE INFORMATION
Get the information you need to take charge of your health. Submit the form below to receive helpful periodic emails with more information and resources.
References: 1. Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12)1209-17. 2. Shaheen NJ, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009, 360:2277-88 3. Vaezi M, Zehrai A, Yuksel E. Testing for refractory gastroesophageal reflux disease. ASGE Leading Edge. 2012;2(2):1-13. American Society Gastroenterology Endoscopy, Pages 1-4. 4. Dymedex Market Development Consulting, GERD Sizing and Segmentation for pH Testing. February 13, 2015. 5. Dymedex Market Development Consulting, Strategic Market Assessment: Barrx-GI, October 30, 2014. 6. SEER Cancer Statistics Factsheets: Esophageal Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/esoph.html. 7. Pohl H, Welch G et al. The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6. 8. SEER Cancer Statistics Animator, 1975-2012. National Cancer Institute. Bethesda, MD.